Combination Therapy with Amylin and Peptide YY[3–36] in Obese Rodents: Anorexigenic Synergy and Weight Loss Additivity
Jonathan D. Roth(Rutgers, The State University of New Jersey), David G. Parkes(Amplyx Pharmaceuticals (United States)), Todd Coffey, Jennifer Athanacio(Amplyx Pharmaceuticals (United States)), Carolyn M. Jodka, Christine M. Mack, Christian Weyer(National Institutes of Health), Holly Maier
Cited by 77
Related Papers
Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia
|The Journal of Clinical Endocrinology & Metabolism|2001|3.4k
Circulating Ghrelin Levels Are Decreased in Human Obesity
|Diabetes|2001|2k
Circulating Interleukin‐6 in Relation to Adiposity, Insulin Action, and Insulin Secretion
|Obesity Research|2001|635